Nostrum Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOSTRUM PHARMS LLC, and what generic and branded alternatives to NOSTRUM PHARMS LLC drugs are available?
NOSTRUM PHARMS LLC has three approved drugs.
Summary for Nostrum Pharms Llc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Nostrum Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-005 | Aug 9, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-003 | Feb 21, 1985 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-002 | Jan 11, 1983 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Nostrum Pharms Llc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 200430-002 | Apr 4, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
